fda drug safety communication semaglutide naion 2025 The obesity (Wegovy) conferred a significantly higher risk of ischemic optic neuropathy (ION) than any other GLP-1 agonist, including semaglutide for diabetes (Ozempic), an analysis of data showed. Added Rybelsus Lawsuit Update May 2026

Patients should inform their healthcare provider about: All current medications, including over-the-counter drugs and supplements Any history of pancreatic or kidney problems Previous diabetic retinopathy diagnosis Pregnancy plans or current pregnancy status When experiencing mild side effects that persist or become bothersome, patients should consult their healthcare provider rather than make medication adjustments independently [17]

Report any suspected side effects to the MHRA Yellow Card Scheme at yellowcard.mhra.gov.uk

This guide exists for exactly that transition

If you are unsure about its storage during your trip, ask your healthcare provider or pharmacist for advice

Were your partner in progress